MedPath

A Proof of Principle Study Investigating the Influence of Diclofenac on Perfusion Changes During Cutaneous Negative Pressure Wound Therapy

Phase 4
Completed
Conditions
Wonden die behandeld kunnen worden met negatieve druk therapie
Wounds
Registration Number
NL-OMON48444
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
18
Inclusion Criteria

* Between 18-35 years of age
* Informed consent
* Male

Exclusion Criteria

* Nicotine abuse
* Gastro-intestinal complaints
* Diclofenac allergy
* Cardiovascular disease
* Neuropathy
* Skin disease of the forearm
* Use of drugs outside of those relating to the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>8.1.1 Main study parameter/endpoint<br /><br><br /><br>The main study parameter of this experiment will be the mean LDF flux of the<br /><br>last 5 minutes of the 20-minute -200 mm Hg NPWT period of the thee study arms. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath